Nonimmunogenic Recombinant Staphylokinase Noninferior to Alteplase for Acute Stroke
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Non-Immunogenic Recombinant Staphylokinase Versus Alteplase for Patients With Acute Ischaemic Stroke 4.5 h After Symptom Onset in Russia (FRIDA): A Randomised, Open Label, Multicentre, Parallel-Group, Non-Inferiority Trial
Lancet Neurol 2021 Sep 01;20(9)721-728, EI Gusev, MY Martynov, AA Nikonov, NA Shamalov, MP Semenov, EA Gerasimets, EB Yarovaya, AM Semenov, AI Archakov, SS MarkinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.